Target Price | €27.50 |
Price | €14.30 |
Potential |
92.31%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target M1 Kliniken 2026 .
The average M1 Kliniken target price is €27.50.
This is
92.31%
register free of charge
€28.00
95.80%
register free of charge
€26.50
85.31%
register free of charge
|
|
A rating was issued by 3 analysts: 3 Analysts recommend M1 Kliniken to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the M1 Kliniken stock has an average upside potential 2026 of
92.31%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million € | 316.32 | 340.78 |
10.88% | 7.73% | |
EBITDA Margin | 6.21% | 8.89% |
21.57% | 43.18% | |
Net Margin | 3.27% | 4.43% |
102.93% | 35.65% |
3 Analysts have issued a sales forecast M1 Kliniken 2024 . The average M1 Kliniken sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an M1 Kliniken EBITDA forecast 2024. The average M1 Kliniken EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast M1 Kliniken 2024 . The average M1 Kliniken net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share € | 0.54 | 0.79 |
125.00% | 46.30% | |
P/E | 18.35 | |
EV/Sales | 0.92 |
1 Analysts have issued a M1 Kliniken forecast for earnings per share. The average M1 Kliniken <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the M1 Kliniken stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
METZLER EQUITIES | Locked ➜ Locked | Locked | Jan 06 2025 |
FIRST BERLIN EQUITY RESEARCH | Locked ➜ Locked | Locked | Dec 19 2024 |
WARBURG RESEARCH GMBH | Locked ➜ Locked | Locked | Nov 20 2024 |
Analyst Rating | Date |
---|---|
Locked
METZLER EQUITIES: Locked ➜ Locked
|
Jan 06 2025 |
Locked
FIRST BERLIN EQUITY RESEARCH: Locked ➜ Locked
|
Dec 19 2024 |
Locked
WARBURG RESEARCH GMBH: Locked ➜ Locked
|
Nov 20 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.